APA (7th ed.) Citation

S, S., AM, T., C, D., M, N., G, R., M, D. N., . . . S, S. (2024). KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 30(20), 4755. https://doi.org/10.1158/1078-0432.CCR-24-0729

Chicago Style (17th ed.) Citation

S, Santagata, et al. "KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 30, no. 20 (2024): 4755. https://doi.org/10.1158/1078-0432.CCR-24-0729.

MLA (9th ed.) Citation

S, Santagata, et al. "KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 30, no. 20, 2024, p. 4755, https://doi.org/10.1158/1078-0432.CCR-24-0729.